CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Unrecognized Tax Benefits in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Charles River Laboratories International, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2010 to Q3 2024.
  • Charles River Laboratories International, Inc. Unrecognized Tax Benefits for the quarter ending September 28, 2024 was $25.2M, a 3.08% decline year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $25.2M -$800K -3.08% Sep 28, 2024 10-Q 2024-11-06
Q2 2024 $24M -$1.6M -6.25% Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $23.4M -$1.1M -4.49% Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $22.7M -$540K -2.32% Dec 30, 2023 10-K 2024-02-14
Q3 2023 $26M -$7.3M -21.9% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $25.6M -$8.9M -25.8% Jul 1, 2023 10-Q 2023-08-09
Q1 2023 $24.5M -$9.7M -28.4% Apr 1, 2023 10-Q 2023-05-11
Q4 2022 $23.2M -$9.35M -28.7% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $33.3M +$4.9M +17.3% Sep 24, 2022 10-Q 2022-11-02
Q2 2022 $34.5M +$7.6M +28.3% Jun 25, 2022 10-Q 2022-08-03
Q1 2022 $34.2M +$8.9M +35.2% Mar 26, 2022 10-Q 2022-05-04
Q4 2021 $32.6M +$7.62M +30.5% Dec 25, 2021 10-K 2024-02-14
Q3 2021 $28.4M +$10M +54.3% Sep 25, 2021 10-Q 2021-11-03
Q2 2021 $26.9M +$9M +50.3% Jun 26, 2021 10-Q 2021-08-04
Q1 2021 $25.3M +$6.2M +32.5% Mar 27, 2021 10-Q 2021-05-04
Q4 2020 $25M +$5.31M +27% Dec 26, 2020 10-K 2024-02-14
Q3 2020 $18.4M -$600K -3.16% Sep 26, 2020 10-Q 2020-11-09
Q2 2020 $17.9M -$6.9M -27.8% Jun 27, 2020 10-Q 2020-08-05
Q1 2020 $19.1M -$400K -2.05% Mar 28, 2020 10-Q 2020-05-07
Q4 2019 $19.7M +$838K +4.45% Dec 28, 2019 10-K 2023-02-22
Q3 2019 $19M -$1.1M -5.47% Sep 28, 2019 10-Q 2019-11-06
Q2 2019 $24.8M +$5M +25.3% Jun 29, 2019 10-Q 2019-07-31
Q1 2019 $19.5M -$1.5M -7.14% Mar 30, 2019 10-Q 2019-05-07
Q4 2018 $18.8M -$5.88M -23.8% Dec 29, 2018 10-K 2022-02-16
Q3 2018 $20.1M -$5.1M -20.2% Sep 29, 2018 10-Q 2018-11-07
Q2 2018 $19.8M -$6.2M -23.8% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $21M -$4.1M -16.3% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $24.7M +$524K +2.17% Dec 30, 2017 10-K 2021-02-17
Q3 2017 $25.2M -$300K -1.18% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $26M +$700K +2.77% Jul 1, 2017 10-Q 2017-08-09
Q1 2017 $25.1M +$1.7M +7.27% Apr 1, 2017 10-Q 2017-05-10
Q4 2016 $24.2M +$848K +3.63% Dec 31, 2016 10-K 2020-02-11
Q3 2016 $25.5M +$3.5M +15.9% Sep 24, 2016 10-Q 2016-11-02
Q2 2016 $25.3M +$2.3M +10% Jun 25, 2016 10-Q 2016-08-03
Q1 2016 $23.4M +$300K +1.3% Mar 26, 2016 10-Q 2016-05-04
Q4 2015 $23.3M -$11.3M -32.6% Dec 26, 2015 10-K 2019-02-13
Q3 2015 $22M -$12.3M -35.9% Sep 26, 2015 10-Q 2015-11-04
Q2 2015 $23M -$11.8M -33.8% Jun 27, 2015 10-Q 2015-07-30
Q1 2015 $23.1M +$7.19M +45.2% Mar 28, 2015 10-Q 2015-04-30
Q4 2014 $34.6M +$16.2M +87.4% Dec 27, 2014 10-K 2018-02-13
Q3 2014 $34.3M +$15.5M +82.6% Sep 27, 2014 10-Q 2014-10-30
Q2 2014 $34.8M +$2.66M +8.27% Jun 28, 2014 10-Q 2014-08-07
Q1 2014 $15.9M -$16.3M -50.6% Mar 29, 2014 10-Q 2014-04-30
Q4 2013 $18.5M -$12.5M -40.4% Dec 28, 2013 10-K 2017-02-14
Q3 2013 $18.8M -$9.29M -33.1% Sep 28, 2013 10-Q 2013-10-30
Q2 2013 $32.1M +$3.23M +11.2% Jun 29, 2013 10-Q 2013-07-31
Q1 2013 $32.2M +$3.51M +12.2% Mar 30, 2013 10-Q 2013-05-08
Q4 2012 $31M +$3.02M +10.8% Dec 29, 2012 10-K 2016-02-12
Q3 2012 $28.1M +$552K +2.01% Sep 29, 2012 10-Q 2012-11-01
Q2 2012 $28.9M -$6.42M -18.2% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $28.7M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $28M -$5.45M -16.3% Dec 31, 2011 10-K 2015-02-17
Q3 2011 $27.5M Sep 24, 2011 10-Q 2011-11-02
Q2 2011 $35.3M Jun 25, 2011 10-Q 2011-08-03
Q4 2010 $33.4M Dec 25, 2010 10-K 2014-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.